Adaptive evolution often involves fast-evolving proteins, and the fastest-evolving 13 proteins in primates include antiviral proteins engaged in an arms race with viruses 14 1-3 . Even though fast-evolving antiviral proteins are the most studied cases of 15 primate host adaptation against viruses, viruses predominantly interact with host 16 proteins that are broadly conserved between distant species in order to complete 17 their replication cycle 4 . Broadly conserved proteins are generally viewed as playing 18 a negligible role in adaptive evolution. Here, we used a dataset of ~4,500 human 19
The arms race between viruses and their hosts has repeatedly involved young, fast-32 evolving antiviral proteins with some of the highest rates of adaptive evolution observed in 33 the proteome. In primates, well-studied examples notably include members of the 34 APOBEC family such as APOBEC3G 1,3 , or members of the TRIM family such as TRIM5a 35 2 . Both proteins have experienced both weak purifying selection and recurrent adaptation 36 during primate evolution and are thought to have evolved very rapidly as a result. 37 APOBEC3G is primate-specific, while TRIM5a is found in primates and a minority of other 38 mammals 5 . While most studies have focused on young, fast evolving proteins typically 39 thought of as the main targets for adaptation, individual examples exist of more broadly 40
conserved VIPs with substantial evidence for adaptation. For example, the antiviral factor 41 PKR/EIF2AK2 has evolved adaptively in a large number of mammals 6,7 ( Fig. 1A ), but we 42 found that it is nevertheless conserved well beyond mammals with clear orthologs in 43 multiple fish genomes according to Ensembl 5 . Moreover, we found that adaptation in PKR 44 has occurred despite strong purifying selection, as shown by low nonsynonymous to 45 synonymous polymorphism ratios (Methods) in both humans 8 and other great apes 46 (chimpanzee,gorilla and orangutan, see Methods) 4,9 .The example of PKR thus shows 47 that abundant adaptation can occur even under the substantial evolutionary constraint that 48 is characteristic of broadly conserved proteins. 
62
Fast-evolving antiviral factors with a limited phylogenetic range are overall not 63 representative of the thousands of host VIPs 4 . We recently assembled a dataset of ~4,500 64
VIPs 10 that together interact with more than 20 different human-infecting viruses 65 (supplementary table 1). VIPs experience stronger purifying selection than non-VIPs 66 (proteins not known to interact with viruses), as shown by a lower average non-67 synonymous over synonymous polymorphism ratio, both in African populations 8 (1.14 vs. 68 1.39, simple permutation test P<10 -9 ) and in great apes 9 (0.62 vs. 0.84, P<10 -9 , Methods). 69 Furthermore, VIPs are conserved across broader phylogenetic distances than non-VIPs 70 ( Fig. 1B,C,D) , with 63% of VIPs having clear orthologs conserved across mammals 4 , 71 versus only 39% for non-VIPs (proportion comparison test P<10 -16 ). Human VIPs are also 72 3.6 times more likely to have a yeast Saccharomyces cerevisiae ortholog in Ensembl 73
Compara than non-VIPs 5 (Fig. 1B ,C, 11% vs. 3%, P<10 -16 ). An elevated proportion of 74 human-yeast orthologs are VIPs (Fig. 1D ), 47% versus only 20% of human protein-coding 75 genes overall. Conversely, VIPs are depleted in younger genes not broadly conserved 76 across mammals compared to non-VIPs ( Fig. 1B for purifying selection and do not suffer from a decrease of statistical power in more 84 conserved proteins 4 . We used two recent versions of the MK test, polyDFE 12 and ABC-85 MK 13 (Methods), to first ask if VIPs had an overall higher rate of adaptation due to viruses 86 compared to non-VIPs -we apply both approaches because they have complementary 87 strengths, so evidence of adaptation obtained by both methods is stronger than either 88 method in isolation. In the main text we put forward the results of polyDFE but also 89 provided the ABC-MK results in Figures 2 and 3 (Methods). We simultaneously controlled 90 for many potential confounding factors using a bootstrap test with multiple target averages 91 (Methods). Note that we excluded immune genes from all subsequent analyses due to 92 concerns related to the potential confounding effect of balancing selection on the MK test 93 4,14 (Methods). The conclusions of our analysis are therefore limited to non-immune genes, 94 and in particular conserved non-immune genes (see below). In agreement with viruses 95 driving elevated rates of adaptation in VIPs, 37% of amino-acid substitutions in VIPs were 96 adaptive during human evolution versus 25% in non-VIPs (bootstrap test P=0.004 for 97 polyDFE, P<10 -3 for ABC-MK; the percentage of amino acid substitutions that were 98 adaptive is noted a). We further found that VIPs not only experienced more adaptation, but 99 also stronger adaptation (selection coefficient s higher than 1%; see Methods) with at least 100 three times more strong adaptation than in non-VIPs (a=14% vs. 5%, P<10 -3 ). We found 101 similar results with ABC-MK, although the overall estimated rate of adaptation was lower 102 (22% in VIPs vs. 8% in control non-VIPs, P<10 -3 , 16% vs. 2% for strong adaptation, P<10 -103 3 ). Note that lower overall estimates are expected with ABC-MK compared to polyDFE 104 (Methods). 105
106
We then asked how the increase in adaptation was distributed across VIPs with 107 different levels of phylogenetic orthologous conservation 5,15 ( Figure 2 ). Unexpectedly, we 108 found no increase and even a decrease of adaptation at VIPs compared to non-VIPs when 109 restricting the comparison to younger genes that do not have broadly conserved orthologs 110 across mammals (Methods; Fig. 2A ,B and 3A,B). This may be due to the fact that the rate 111 of adaptation is elevated in these genes overall, including in non-VIPs ( Fig. 2A,B and 112 3A,B). By contrast, we found much higher adaptation in VIPs compared to non-VIPs with 113 broader phylogenetic conservation. We estimated a=43% in VIPs that are conserved in 114 mammals, versus 15% in similarly conserved control non-VIPs ( Fig. 2A,B and 3C,D). 115
Adaptation in VIPs was also much stronger, with a=17% for strong adaptation (s>1%) in 116
VIPs versus 3% for non-VIPs ( Fig. 3C,D) . The estimated a remained at 39% in VIPs 117 conserved across bilaterians, and at 15% for strong adaptation ( Fig. 2A,B and 3E,F). 118 Adaptation was very low in similarly conserved control non-VIPs, with a=5% overall and 119 0.4% for strong adaptation ( Fig. 2A,B and 3E,F). Remarkably, a still remained at 43% 120 overall and 17% for strong adaptation in VIPs shared between animals and fungi while 121 being estimated even closer to zero at 2% overall (0.3% for strong adaptation) in similarly 122 conserved control non-VIPs ( Fig. 2A,B and 3G,H). These results were robust to the choice 123 of method used to annotate orthologous conservation 5,15 (Extended Data Fig. 1 ), and 124 suggest that the rate of adaptation at VIPs remains stable across levels of phylogenetic 125 conservation, while at the same time higher levels of conservation have strongly limited 126 adaptation in non-VIPs. Furthermore, broadly conserved proteins that interact with multiple 127 viruses experienced strongly increased adaptation, as expected if viruses were indeed the 128 
149
Broadly conserved proteins therefore experienced sharply different patterns of 150 evolution, depending on whether they interact with viruses or not. VIPs have experienced 151 substantial adaptation, and particularly strong adaptive events. An important consequence 152 is that the majority of human adaptation in broadly conserved proteins, and especially 153 strong adaptation, was likely driven by viruses. We quantified the proportion of all adaptive 154 amino acid changes that were driven by viruses at different breadths of conservation 155 (Methods). In proteins conserved in mammals, we estimated that viruses drove 28% of all 156 adaptation (Methods), 55% for proteins conserved in bilaterians, and 95% for proteins 157 conserved between animals and fungi (25%, 56% and 78% for ABC-MK estimates, 158 respectively). For strong adaptation (s>1%), we estimated that 40% of strong adaptive 159 events may have been driven by viruses in proteins conserved across mammals, 85% in 160 proteins conserved across bilaterians and 98% for proteins conserved across animals and 161 fungi (45%, 64% and 84% for ABC-MK, respectively). Other types of pathogens such as 162 bacteria or eukaryotic pathogens have not supported a similar level of impact on 163 conserved proteins 16 (SI). Therefore, viruses have likely ruled over adaptation in the 164 conserved human proteome. Interestingly, different viruses (supplementary table 1) had 165 similar contributions to adaptation in broadly conserved proteins, and no single virus that 166 we tested represented and unusually large proportion of adaptive events (SI). 167 168 Together, these results paint an unexpected picture of proteome-wide adaptation 169 against viruses that cannot be inferred from generalizing the known examples of young, 170 fast-evolving antiviral proteins 1-3 . Our analyses show that viruses do not seem to increase 171 overall adaptation in non-immune, younger proteins -in contrast, viruses drive the vast 172 majority of strong adaptation events in broadly conserved proteins. However, because they 173 are specialized in restricting viruses, fast-evolving, immune antiviral proteins can 174 accumulate many protective adaptive substitutions, and thus undoubtedly represent highly 175 significant players in the arms race with viruses. This nonetheless raises the question of 176 why viruses, if they represent such a strong selective pressure, do not increase overall 177 adaptation in younger non-immune VIPs. One possible explanation is that young VIPs 178
have not interacted with very many viruses during evolution. However, younger VIPs 179 interact with significantly, but only slightly fewer viruses on average compared to VIPs 180 conserved in mammals (1.73 vs. 1.91 respectively, simple permutation test P<10 -3 ). 181
Another possible explanation is that viruses are only one of many other selective 182 pressures experienced by younger proteins, as shown by the high levels of adaptation in 183 younger non-VIPs. We also cannot fully exclude that an increase in adaptation in younger 184 
VIPs dataset 195
The dataset of VIPs has been extensively described 4,10 . Supplementary table 1 
Constraint in PKR/EIF2AK2 207
We measured level of constraint in PKR/EIF2AK2 as the ratio of non-synonymous 208 polymorphism over synonymous polymorphism both in both humans 8 and other great 209 apes (chimpanzee,gorilla and orangutan) 4,9 . In humans we used polymorphism in African 210 populations from the 1000 Genomes Project phase 3 8 . In great apes, we summed the 211 non-synonymous polymorphism over chimpanzee, gorilla and orangutan populations 212 included in the Great Apes Genome Project 4,9 , and did the same for synonymous 213 polymorphism. More specifically we used the ratio of the number of non-synonymous 214 variants over the number of synonymous variants plus one to avoid null denominators 215 (noted pN/(pS+1)). 216
In human African populations, for PKR/EIF2AK2 pN/(pS+1)=5/12=0.42 vs. 1.27 for 217 the proteome average. This represents the 46 th lowest ratio out of 496 coding sequences 218 with the same number of variants (pN+pS). In great apes, pN/(pS+1)=3/14=0.21 vs. 0.91 219 for the proteome average. This is the 71 st lowest ratio out of 476 coding sequences with 220 the same number of variants. In summary, the low pN/(pS+1) ratio in both humans and 221 other great apes shows that PKR/EIF2AK2 has experienced both strong constraint and 222 intense adaptation. 223
224

Divergence and polymorphism data 225
The divergence and polymorphism data used for this study have already been described in 226 detail in Uricchio et al. 13 . In brief, we used human-chimpanzee-orangutan alignments of 227 17,740 orthologous coding sequences to identify fixed substitutions on the human branch. In order to verify that our results were not sensitive to a specific version of the MK test, we 235 used two implementations of the MK test that use different approaches, namely polyDFE 12 236 and the ABC-MK test 13 . The polyDFE implementation of the MK test uses a maximum 237 likelihood approach, while ABC-MK uses Approximate Bayesian Computation to estimate 238 a, the proportion of adaptive amino acid changes that were adaptive in a given 239 evolutionary lineage. Compared to other existing methods, both polyDFE and ABC-MK do 240 not make the simplifying assumption that advantageous mutations do not contribute to 241 polymorphism. This assumption can be problematic when a substantial proportion of 242 adaptation is weak adaptation, with adaptive mutations taking a longer time to go to 243 fixation, as may be the case in human evolution 13 . Both polyDFE and ABC-MK account for 244 the contribution of weakly advantageous mutations and use this contribution to estimate 245 separate rates of weakly and strongly advantageous substitutions. This ability to 246 distinguish between weak and strong adaptation is important to estimate the overall a 247 accurately. It is also important for this specific study, to determine whether a specific a in 248 conserved coding sequences reflects only weak adaptation with limited fitness 249 implications, or instead strong adaptation with important fitness implications and potentially 250 substantial functional consequences. Segregating weakly advantageous mutations are 251 explicitly integrated in the model used by polyDFE given that polyDFE estimates the full 252 distribution of fitness effects, while in ABC-MK it is the shape of the a-curve as a function 253 of derived allele frequency that is determined by the abundance and frequency of 254 segregating weakly advantageous variants. 255
In addition to distinguishing between weakly and strongly advantageous 256 substitutions, polyDFE and ABC-MK each have other complementary advantages. Indeed, 257 polyDFE has the advantage that it can estimate a solely from polymorphism data without 258 requiring divergence information. This is important because estimates of a can lose 259 accuracy due to long-term changes in population sizes 17 . For example, current estimates 260 of modern human effective population sizes are smaller than the older effective population 261 sizes that have been estimated for earlier human evolution, closer to the split with 262 chimpanzee 18-20 . This means that modern humans have likely experienced weaker 263 purifying selection compared to earlier human evolution. The issue then is that the current 264 number of non-synonymous variants is higher than the long-term number of non-265 synonymous variants, due to more effectively neutral deleterious variants segregating and 266 even sometimes fixing. Such variants would have been eliminated under earlier higher 267 population sizes. At the same time, the long-term number of non-synonymous variants 268 available for fixation, not the higher current number, determines the number of fixed non-269 synonymous substitutions. If not taken into account, the currently higher number of non-270 synonymous variants then results in underestimating a in human evolution 13 . By avoiding 271 using divergence altogether, polyDFE also avoids this potential discrepancy between the 272 current and the long-term numbers of non-synonymous variants. Note however that the 273 fact that polyDFE uses only polymorphism implies that the estimated a are only 274
representative of more recent human evolution. considering Ne~10,000 in modern humans. Considering a generation time between 25 and 311 30 years 23 , polyDFE would then capture the last 500,000 to 600,000 years of human 312 adaptive evolution. Note however that this reasoning neglects the fact that even older 313 adaptive events that brought advantageous variants to higher frequencies could still 314 participate in the differences between the SFS of non-synonymous and synonymous 315 variants, even long after the driving selective pressures have disappeared 24 . Although it is 316 thus unclear how much evolutionary time is captured by polyDFE, it is very likely to be 317 much less than the divergence time between humans and chimpanzee. 318 ABC-MK uses divergence and thus reflects human evolution since divergence with 319 chimpanzee. We therefore do not expect to estimate the same a with polyDFE and ABC-320 MK. The a estimates from ABC-MK may also represent underestimates (see above) due 321 to long-term population size fluctuations, which may further explain the differences 322 observed between polyDFE and ABC-MK. In support of this, we noticed that while 323 polyDFE based on polymorphism estimated a close to zero (2%) in non-VIPs broadly 324 conserved between humans and yeast, polyDFE based on polymorphism and divergence 325 estimated a substantially negative a (-15%) for the same proteins. This suggests that the 326 downward bias due to ancient population size fluctuations becomes apparent in the form of 327 negative a estimates in proteins that experience very little adaptation, but where a should 328 still be positive and very close to zero. It is interesting to note that the 17% difference (2% 329 to -15%) between the two estimates of polyDFE used with or without divergence matches 330 well the differences observed at all VIPs between polyDFE and ABC-MK (37% vs. 22%). 331
For these reasons we chose to put forward the results of polyDFE based on 332 polymorphism only in the main text, although it represents adaptation in relatively recent 333 human evolution. The polyDFE version of the MK test also likely better accounts for very 334 weakly advantageous mutations compared to ABC-MK. Indeed, the ABC-MK version of 335 the MK test assumes weakly advantageous mutations with 2Ns=10, but not lower 13 , 336
whereas polyDFE does not have such a limitation. This predicts that ABC-MK may 337 underestimate a by not including very weakly advantageous mutations with 2Ns below 10. 338
Note that it is a matter of debate whether such weakly advantageous mutations that 339
behave like nearly neutral mutations should be considered as advantageous in the first 340 place 25 . 341 342
Estimating the contribution of viruses to total adaptation 343
In addition to estimating a, we used a in VIPs and non-VIPs to estimate how much 344 adaptation was driven by viruses. We defined the contribution of viruses to total protein 345 adaptation as the percentage of all adaptive amino acid changes that were driven by 346 viruses. In VIPs, not all adaptive amino acid changes were necessarily driven by viruses. 347
As an estimate of the baseline adaptation in VIPs in the absence of viruses, we used the 
Sets of conserved, orthologous proteins 368
For our analysis, we used only orthologs that are more likely to be conserved not only at 369 the sequence level but also at the functional level compared to other types of homologs 15 . 370
Viruses tend to target conserved cellular functions for their replication 4,26 . To ensure that 371
we worked with human genes that not only had partial sequence conservation, but also 372 more likely functional conservation, we only included, one to one, best reciprocal 373 orthologs. Such orthologs are less likely to evade the selective pressure of viruses by 374 redistributing the targeted host functions through duplication and the formation of paralogs. 375
Adaptation in such conserved functions is therefore more likely to have to happen at the 376 orthologous sequence level. 377
The different sets of conserved proteins we used are based on orthology information from 378 a previous study of VIPs in mammals 4 and from the Ensembl Compara database 5 . In a 379 previous study we identified 9,589 human coding sequences (CDS) that are best-380 reciprocal homology hits between human CDS and the CDS of 23 other eutherian 381 mammals, still have the same Ensembl Identifiers as in our previous study in Ensembl v83, 382 and are included in the 17,740 human-chimp-orangutan orthologs that we used 383 (supplementary table 3 ). These 9,589 CDS represent the set of CDS broadly conserved 384 across mammals (Figs. 2 and 3 ). Of these 9,589 CDS, we used 7,681 non-immune that 385 had information for all the confounding factors taken into account by the bootstrap test 386 (supplementary table 1). These 7,681 CDS only include CDS with non-zero (>0.0005 387 cM/Mb over a 200kb window centered half-way between the genomic start and the 388 genomic end of each gene) recombination rates to avoid gaps in the recombination map 389 we used 27 . These 7,681 CDS include 2,106 VIPs (supplementary In addition to the Ensembl Compara orthologs, we verified that our results were 408 robust to the particular annotation tools of orthologs by using predictions of orthologs from 409
Wormhole 15 . that provides machine learning predictions of orthologs based on the 410 integration of 17 different ortholog prediction algorithms. Wormhole provides scores of 411 confidence for orthology predictions ranging from zero to one, from low to high confidence. 412
We validated the robustness of the results found with Ensembl Compara by using 413
Wormhole best reciprocal orthologs with confidence score above 0.5 or 0.9. The number of 414 orthologous VIPs between human and Drosophila melanogaster or between human and 415 yeast varied substantially as a function of the confidence score (Extended Data Fig. 1) . 416
However, the estimates of adaptation in VIPs and control non-VIPs remained very similar 417 (Extended Data Fig. 1) , showing that these results are robust to the particular set of 418 orthologs used. 419 420
Confounding factors 421
An important hurdle when trying to detect the impact of a specific selective pressure by 422 quantifying adaptation in associated genes (VIPs to detect the impact of viruses in our 423 case) is that these genes may also vary in different other ways that also affect rates of 424 adaptation compared to the rest of the genome. For example, VIPs are more highly 425 expressed across many tissues than non-VIPs 4,10,26 , and stronger expression could 426 hypothetically lead to higher rates of adaptation in VIPs in an indirect way that has nothing 427 to do with a causal impact of viruses. In order to account for such potential confounding 428 factors, we adopted an exhaustive approach and included as many possible confounding 429 factors as we could think of based on previous literature and available data. In total, we 430 included 13 different factors that could have an impact on the estimation of a 431 (supplementary table 2). These factors include: 432 433 -DS: the number of fixed synonymous substitutions in humans since divergence with 434 chimpanzee. Controlling for DS accounts for any bias that would affect a through DS 435 rather than through the effect of adaptation on DN, the number of non-synonymous fixed 436 substitutions. 437 -PN and PS: we matched sets of VIPs with control sets of non-VIPs with the same average 438 number of non-synonymous variants PN in African populations, and the same number of 439 synonymous variants PS. We matched PS for the same reason as DS. We matched PN to 440 build control sets of non-VIPs with the same average amount of strong purifying selection 441 as VIPs. Indeed, the stronger the purifying selection, the higher the number of amino acid 442 changing positions where mutations are not tolerated even at low frequencies. 443 -GC content. GC content correlates with many other potential confounding factors and is a 444 good proxy for long-term recombination rate. Matching GC content thus controls for 445 potential confounders such as biased gene conversion and long-term recombination rate 446
28 . We used the GC content measured in 50kb windows centered on genes, half-way 447 between gene starts end gene ends. 448 -recombination rate. Local recombination rate can have a profound impact on adaptation 449 by affecting the amount of linkage with deleterious or other advantageous mutations and 450 by affecting the levels of background selection. We therefore matched VIPs with control 451 non-VIPs with a similar recombination rate from the genetic map of Hinch et al. 27 . The 452 recombination rates were estimated in 200kb windows centered half-way between the 453 genomic start and genomic end of Ensembl protein coding genes genes. We excluded any 454 VIP and non-VIP with a recombination rate less than 0.0005 cM/Mb from our analysis to 455 avoid confusing genes where the recombination rate is actually close to zero, and genes 456
where there is simply a gap in the genetic map (missing data). 
Accounting for confounding factors: the bootstrap test with multiple target averages 490
We created a bootstrap test called the bootstrap test with multiple target averages to 491 match VIPs with control sets of non-VIPs. Previously we had created a bootstrap with only 492 one target average for only one factor 4 . For a given set of VIPs, we build a control set of 493 non-VIPs that that has the same overall average values for all the 13 factors described 494 above. The matching process represents a bootstrap because the same non-VIP can be 495 resampled and represented multiple times in the control set of non-VIPs. We build the 496 control sets of non-VIPs gradually until the number of non-VIPs matches the number of 497
VIPs tested (counting non-VIPs sampled multiple times as many times as they appear in 498 the control set). Each non-VIP is sampled randomly and added to the control set if the 499 averages for the 13 factors in the growing control set all stay within matching limits defined 500 around the VIP average. These matching limits are defined as follows. If a factor is on 501 average higher in VIPs compared to non-VIPs as is for example the case for overall gene 502 expression, we define a lower bound at 0.95 times the VIP average for the control set of 503 non-VIPs. In this case we do not set a higher bound because the randomly sampled non-504
VIPs tend to have much lower expression than VIPs anyways. If a factor is on average 505 lower in VIPs compared to non-VIPs as is for example the case for the number of non-506 synonymous variants PN, we define an upper bound at 1.05 times the VIP average for the 507 control set of non-VIPs. In this case we do not set a lower bound because the randomly 508 sampled non-VIPs tend to have much higher PN than VIPs. Furthermore, in the cases 509
where not enough matching non-VIPs are found and the matching process takes too long, 510
we slightly expand the lower and higher bounds of the permissible range. We expanded 511 the permissible range to plus or minus 7% for the test with genes broadly conserved in 512 animals and fungi (Figs. 2 and 3 ), and to plus or minus 10% for tests with VIPs that interact 513 with two or more viruses (Extended Data Fig. 2) . We sample non-VIPs as potential 514 controls only if they are located 50kb or further from VIPs. We do this because neighboring 515 genes tend to be functionally more similar, which means there could be a chance that non-516
VIPs close to VIPs might be more likely to be yet undiscovered VIPs. Although the same 517 non-VIPs can be represented multiple times in the bootstrap control set, we set a limit that 518 each individual non-VIP cannot represent more than 2% of the control set. 519 520 An important difficulty when gradually building control sets of non-VIPs while trying 521 to simultaneously match 13 different factors is that only a small proportion of individual 522 non-VIPs in the genome may actually match closely the combination of averages across 523 13 different factors. This can be problematic when starting to build a control set of non-524
VIPs, because the first non-VIPs that would result in averages close to the VIP set 525 averages are VIPs that are themselves close to the averages. This is a problem because 526 many more diverse combinations of non-VIPs can collectively match the VIP averages, 527 while individually not matching these averages at all (by compensating each other). In 528 order to ensure that we select control sets of non-VIPs that include as many non-VIPs as 529 possible and not only the non-VIPs that happen to closely match the VIP set averages, we 530 use a starting group of 50 "fake non-VIPs" that all individually match the VIP set averages 531 perfectly. We then gradually add real non-VIPs to this fake set of non-VIPs. Then, even if 532 the first added real non-VIP has factor values far from the VIP set averages, there is still a 533 good chance that the averages of all factors for the 50 fake + 1 real non-VIPs will still be 534 within the authorized range of averages. If the 50 fake and one real non-VIPs are within 535 the authorized average range, we keep the real non-VIP and we remove one fake non-VIP 536 supposed to perfectly match the VIP set average. We then verify that the average for the 537 49 remaining fake non-VIPs and the one real non-VIP also fall within the acceptable range. 538
We then repeat the addition of a real non-VIP and removal of a fake non-VIP until there 539 are no fake non-VIPs left, at which point we simply start adding non-VIPs to the 50 first 540 real non-VIPs. This procedure ensures that the control set of non-VIPs includes non-VIPs 541 with diverse combinations of factors' values while still matching VIPs in terms of overall 542 averages. In this manuscript, for each comparison of VIPs with non-VIPs, we created 543 1,000 sets of control non-VIPs. We also did not actually add non-VIPs to growing sets of 544 non-VIPs one by one, but two by two, because it also increased the number of VIPs that 545 could be used as controls due to the compensation effect between pairs of different non-546
VIPs whose average for confounding factors happens to fall closer to the target averages. 547 548
Balancing selection and the MK test 549
Balancing selection such as frequency-dependent selection or heterozygous 550 advantage can maintain functional variants at intermediate frequencies. Such balanced 551 variants could potentially affect estimates of a by the MK test if they are common enough, 552 especially at immune genes or genes interacting with pathogens in general 14 . This would 553 specifically happen in the case where balancing selection increases the number of non-554 synonymous variants at intermediate frequencies, which is expected to result in 555 underestimating a. In a previous study 4 , we found that a for immune VIPs (VIPs with GO 556 immune annotations) is lower than a at immune non-VIPs. No such pattern was observed 557 when comparing non-immune VIPs and non-immune non-VIPs. We speculated at the time 558 that it could be due to balancing selection increasing the number of non-synonymous 559 variants at intermediate frequencies in immune VIPs. Here, we tested this hypothesis with 560 the new, larger set of 4,494 VIPs. To test if immune VIPs experienced balancing selection 561 increasing the number of intermediate-frequency non-synonymous variants, we tested if 562 they have an increased number of non-synonymous variants at derived allele frequencies 563 between 0.4 and 0.6 (close to 0.5) compared to 1,000 control sets of non-VIPs built using 564 the bootstrap test with multiple target averages (see above, factors same as the other tests 565 conducted in the manuscript). Note that this comparison is conservative given that overall 566 the number of non-synonymous variants in VIPs is lower than in non-VIPs due to stronger 567 purifying selection in VIPs. Despite the conservativeness of the test, we did find a 568 significantly higher number of non-synonymous variants at (78 vs. 58.7 expected on 569 average, bootstrap test P=0.023), suggesting that balancing selection might indeed have 570 increased non-synonymous variation at intermediate frequencies. Thus, because of the 571 potential underestimating effect of balancing selection on a in immune VIPs but also in 572 other immune genes 14 , we decided as a precaution to not include immune genes in any of 573 the analyses conducted in the manuscript. Importantly, excluding immune genes does not 574 change the main result that adaptation in broadly conserved proteins is mostly driven by 575 viruses. Removing immune genes is also justified by the fact that it is already very-well 576 broadly conserved in animals and fungi was too low to get reliable estimates, with confidence intervals for a 683 ranging from zero to one, showing insufficient information for convergence of polyDFE.
685
Supplementary Information 686 687
Supplementary table 1 is provided as an excel spreadsheet. 688 689
Testing the impact of specific viruses 690
We tested whether specific viruses drove more or less adaptation compared to 691 other viruses in conserved proteins. For each of 11 viruses with more than 50 testable 692
VIPs conserved across mammals, we used polyDFE to measure a. We then compared the 693 estimated a for the tested virus with the estimates obtained from controls sets of VIPs that 694 interact with other viruses. The set of VIPs for the tested virus and the control VIPs that 695 interact with other viruses were matched for the number of viruses they interact with using 696 the bootstrap test. This was done to avoid confusing the effect of a specific virus with the 697 possibility that the VIPs of a specific virus might just happen to interact with more viruses 698 than the average VIP. We further only used control VIPs that are at least 50kb away from 699 the VIPs for the tested virus. This was done to account for the fact that neighboring genes 700 
